Cargando…
Prognostic impact of six versus eight cycles of standard regimen in patients with diffuse large B-cell lymphoma: propensity score-matching analysis
BACKGROUND: R-CHOP-21 has been the standard treatment for diffuse large B-cell lymphoma (DLBCL), but there is a paucity of evidence focusing on the number of cycles of regimens. PATIENTS AND METHODS: We conducted a retrospective study to compare the effectiveness of six cycles of standard regimens v...
Autores principales: | Oiwa, K., Fujita, K., Lee, S., Morishita, T., Tsukasaki, H., Negoro, E., Hara, T., Tsurumi, H., Ueda, T., Yamauchi, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287142/ https://www.ncbi.nlm.nih.gov/pubmed/34271313 http://dx.doi.org/10.1016/j.esmoop.2021.100210 |
Ejemplares similares
-
The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma
por: Lee, Shin, et al.
Publicado: (2023) -
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma
por: Oiwa, Kana, et al.
Publicado: (2023) -
3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis
por: Araie, Hiroaki, et al.
Publicado: (2017) -
New agents and regimens for diffuse large B cell lymphoma
por: Wang, Liang, et al.
Publicado: (2020) -
Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis
por: Gao, Rui, et al.
Publicado: (2019)